The new results show that people with a specific version of a gene are less likely to develop severe COVID-19. Earlier research had identified
vaccine
Scientists scrutinise characteristics of new Omicron sub-variant
Image Credit:CIPhotos via Getty Images Studies are underway to find out the precise characteristics of the latest Covid-19 variant ‘BA.2’. It already accounts
AUSTRIA ADDS A LOTTERY TO COVID VACCINE MANDATE
A doctor vaccinates a person with a dose of the Pfizer-BioNTech COVID-19 vaccine in Vienna, Austria April 26, 2021. REUTERS/Lisi Niesner Austria’s conservative government
CHEAP VERSION OF MERCK COVID PILL TO BE MADE FOR POORER NATIONS
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated
WHO says no evidence healthy children, adolescents need COVID-19 boosters
Photo Credit: Fabrice Coffrini | Reuters At present, there is no evidence that healthy children and adolescents need booster doses of the COVID-19 vaccine,
Pfizer CEO: Virus will be here for years but this may be last wave with restrictions
Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on October 12, 2021. (AP Photo/Giannis Papanikos, File) Pfizer CEO Albert Bourla said
A healthcare worker administers…
A healthcare worker administers the coronavirus disease (COVID-19) vaccine to a pregnant woman, amidst the spread of the SARS-CoV-2 variant Omicron, in Johannesburg, South
AstraZeneca says third dose helps against Omicron
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration AstraZeneca
Omicron May Infect Half of Europeans Within Weeks, WHO Says
Image Credit:CIPhotos via Getty Images More than half of Europe’s population could become infected with omicron within weeks at current transmission speeds, a World
MODERNA CEO SAYS PEOPLE MAY NEED ANOTHER BOOSTER IN FALL OF 2022
A pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike Segar The effectiveness